Abstract Title: currently loading...

information currently loading...

Loading ... please wait
timer Loading ... please wait

Free Paper Session 16: Vascular Diseases Session

Date/Time: | Room:

Back to Previous



11:00:00 R. Patel United Kingdom The management of neovascular retinal vein occlusions in post intravitreal treatment patients
11:06:00 T. Qian China Correlation between polyp size and presence of blood flow signals in polyps by optical coherence tomography angiography for polypoidal choroidal vasculopathy
11:12:00 P. Brito Portugal Association of peripheral blood proinflammatory factors with intravitreal corticosteroid treatment in persistent diabetic macular edema
11:18:00 S. Vasudevan India Oct biomarkers in refractory DME Boon or bane ?
11:24:00 T. Ozturk Turkey Comparison of the outcomes of two different intravitreal treatment protocols in treatmentnaive phakic eyes with macular vein occlusion
11:30:00 C. Isanta Otal Spain Influence of arterial hypertension on choroidal thinning in type 2 diabetic patients
11:36:00 O. Ruiz Moreno Spain Relationship between mean haemoglobin A1c levels for 5 years and diabetic retinopathy and choroidopathy
11:42:00 R. Marques Portugal Vascular retinopathy screening in pregnancy – results from a crosssectional study
11:48:00 A. Campos Portugal Evaluation of markers of outcome in diabetic macular edema
11:54:00 F. Romano Italy Visual outcomes after intravitreal ranibizumab for macular edema secondary to juvenile central retinal vein occlusion
12:00:00 P. Mitchell Australia Evolution of baseline characteristics of treatmentnaïve patients with diabetic macular edema over 4 years of enrollment into the LUMINOUS study
12:06:00 F. Ghassemi Iran, Islamic Republic of Randomized clinical trial of intravitreal bevacizumab versus intravitreal bevacizumab combined with losartan in the treatment of diabetic macular edema
12:12:00 M. Ribeiro Portugal Microaneurysm turnover is a predictor of diabetic retinopathy progression
12:18:00 D. Bhatia United Kingdom Evaluation of the symmetry of functional response to Intravitreal Aflibercept treatment for bilateral diabetic macular oedema: Realworld outcomes

Want to find out more about EURETINA activities?

Contact us
© EURETINA All rights reserved